101
|
Ketelsen UP, Beckmann R, Zimmermann H, Sauer M. Inclusion body myositis. A "slow-virus" infection of skeletal musculature? KLINISCHE WOCHENSCHRIFT 1977; 55:1063-6. [PMID: 926717 DOI: 10.1007/bf01489481] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
We report the case of a 56-years old patient with clinical symptoms of an unresolved neuromuscular disease. The light microscopic studies of a muscle biopsy from the m. triceps shows the picture of a diffuse muscular atrophy. By electron microscopy, myelin-like degeneration zones with tubular-filamentous inclusions can be shown in the cytoplasma of the atrophic muscle cells. These filamentous structures correspond morphologically to the nucleocapside of paramyxoviruses. These results lead, even without the proof of inflammatory cells, to the diagnosis of an "inclusion body" myositis also taking into account the clinical and electrophysiological findings.
Collapse
|
102
|
Fitschen J, Beckmann R, Holm U, Neuert H. Yield and production of 18F by 3He irradiation of water. ACTA ACUST UNITED AC 1977. [DOI: 10.1016/0020-708x(77)90109-0] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
103
|
|
104
|
Koschinsky T, Gries FA, Schwandt P, Weisweiler P, Hansen W, Nijssen J, Beckmann R. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)]. MMW, MUNCHENER MEDIZINISCHE WOCHENSCHRIFT 1977; 119:701-4. [PMID: 195201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
21 patients with primary hyperlipoproteinemias of type IIb and IV were treated for 8 weeks with placebo, 8 weeks with 0.3 g butylbiguanide and 1.5 g clofibrate/day and then for 8 weeks with 1.5 g clofibrate/day. In 12 patients a second placebo phase of 8 weeks followed. After 8 weeks of combined treatment with butylbiguanide and clofibrate the serum triglycerides decreased from 725 mg to 269 mg/100 ml. During the following period of clofibrate treatment the serum triglycerides increased after 4 and 8 weeks to 326 mg and 306 mg/100 ml respectively. The combined treatment with 0.3 g butylbiguanide and 1.5 g clofibrate/day is more effective in lowering elevated serum triglycerides and cholesterol than 1.5 g clofibrate alone.
Collapse
|
105
|
Beckmann R, Ketelsen UP. [Lipid-storage muscular diseases--newly diagnosed benign myopathies]. MONATSSCHRIFT FUR KINDERHEILKUNDE 1977; 125:500-1. [PMID: 876219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
106
|
Beckmann R, Ketelsen UP. [Hazards in the administration of depot corticoids, especially in childhood and adolescence]. Dtsch Med Wochenschr 1977; 102:587-8. [PMID: 849715] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
107
|
Beckmann R. Detection of preclinical Duchenne muscular dystrophy and its female carriers. ISRAEL JOURNAL OF MEDICAL SCIENCES 1977; 13:102-6. [PMID: 863671] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
108
|
Beckmann R, Scheuerbrandt G, Antonik A. [Diagnosis of preclinical Duchenne's muscular dystrophy in the newborn using the CK screening test]. MONATSSCHRIFT FUR KINDERHEILKUNDE 1976; 129:658-9. [PMID: 979985] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
109
|
Beckmann R, Schmit B. [The heart in muscular diseases. 1. Muscular dystrophy, especially Duchenne's muscular dystrophy]. MEDIZINISCHE KLINIK 1976; 71:1135-45. [PMID: 781499] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
110
|
Lintz W, Berger W, Aenishaenslin W, Kutova V, Baerlocher C, Kapp JP, Beckmann R. Butylbiguanide concentration in plasma, liver, and intestine after intravenous and oral administration to man. Eur J Clin Pharmacol 1974; 7:433-48. [PMID: 4439867 DOI: 10.1007/bf00560356] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
111
|
Beckmann R. [Clinically significant congenital myopathies]. MEDIZINISCHE KLINIK 1974; 69:1175-84. [PMID: 4603414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
112
|
Emrich D, Lindner J, Zimmermann HD, Beckmann R. Influence of hemithyroidectomy on endogenously labelled thyroxine and tri-iodothyronine in rats. J Endocrinol 1972; 55:479-87. [PMID: 4647459 DOI: 10.1677/joe.0.0550479] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
SUMMARY
In order to investigate the influence of thyroid-stimulating hormone (TSH) on the ratio of newly synthesized thyroxine( T4):tri-iodothyronine (T3), hemithyroidectomy was performed on rats maintained on an iodinerich diet. One and two weeks after the operation the concentration of TSH increased in the plasma. As a result, the weight of the residual lobes and their thyroidal uptake of 131I/mg increased and significant histological signs of increased function in the remaining lobes were observed. The most prominent effect was a significant alteration of the ratio of newly synthesized T4:T3 in favour of T3, both in the thyroid and plasma. Four weeks after the operation, when the residual lobes weighed 57% more than those in the controls, the alterations decreased or returned to normal. The total hormone concentration in the plasma (measured as protein-bound 127I) and the oxygen consumption of the animals remained unchanged during the entire study. These findings support the hypothesis that alteration of the production and secretion ratio of T4:T3 induced by TSH might act as another regulatory factor, if a hormone deficiency originates in the peripheral cells. The results show also that changes of the T4:T3 ratio induced by TSH occur in animals on an iodine-rich diet.
Collapse
|
113
|
Beckmann R. [Clinical aspects and therapy of muscular dystrophies]. Internist (Berl) 1972; 13:108-17. [PMID: 4553893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
114
|
Beckmann R. [Anabolic steroid hormones and progressive muscular dystrophy]. Dtsch Med Wochenschr 1972; 97:213. [PMID: 5058209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
115
|
Beckmann R, Clotten R, Aga AE. [Urinary amino acids in children and adults with normal metabolism]. KLINISCHE PADIATRIE 1972; 184:18-26. [PMID: 5063474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
116
|
Ketelsen UP, Freund-Mölbert E, Beckmann R. [Clinical and ultrastructural findings in congenital muscular dystrophy]. MONATSSCHRIFT FUR KINDERHEILKUNDE 1971; 119:586-92. [PMID: 5133645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
117
|
Emrich D, Burmeister G, Zimmermann HD, Beckmann R. The effect of iodine deficiency and suppression of TSH secretion on radioiodine labelled thyroxine and triiodothyronine in the thyroid of rats. ACTA ENDOCRINOLOGICA 1971; 68:377-86. [PMID: 4108314 DOI: 10.1530/acta.0.0680377] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
ABSTRACT
It has been suggested that TSH stimulation of the thyroid gland is accompanied by an alteration in the ratio of newly synthesized thyroxine (*T4)1)/triiodothyronine (*T3) in favour of *T3. Evidence in support of this hypothesis is provided here by the finding that suppression of TSH secretion in rats alters this ratio in the other direction, i. e. in favour of *T4.
Thus, endogenous TSH stimulation was increased for 4 weeks by iodine deficiency. Its suppression was performed by the administration of T3, using a dose of 0.05-0.25 μg/100 g body weight which was injected subcutaneously every 12 hours for three days. The effect of TSH stimulation and suppression could be assessed from the following parameters: thyroid weight and histology, thyroid 131I uptake, 131I conversion ratio, hormonal iodine concentration, and TSH level in the plasma. After iodine deficiency the ratio of *T4/*T3 in the thyroid gland changed in favour of *T3. This may compensate for the iodine deficiency, since the oxygen consumption and the heart rate of the animals remained in the normal range. After suppression the ratio of *T4/*T3 changed in the opposite direction, i. e. in favour of *T4. The extent of the suppression of *T4 and *T3 was dependent on the suppression dose used.
Collapse
|
118
|
Beckmann R, Lintz W, Schmidt-Böthelt E. Evaluation of a sustained release form of the oral antidiabetic butylbiguanide (Silubin retard). Eur J Clin Pharmacol 1971; 3:221-8. [PMID: 5151304 DOI: 10.1007/bf00565010] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
119
|
Beckmann R. [Therapy of progressive muscular dystrophy]. MEDIZINISCHE KLINIK 1971; 66:1099. [PMID: 5562103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
120
|
Beckmann R, Lintz W, Nijssen J. [Increase in 14CO2 formation from 14C-glucose in rats caused by the oral antidiabetic butylbiguanide hydrochloride]. EXPERIENTIA 1971; 27:127-9. [PMID: 5544709 DOI: 10.1007/bf02145848] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
121
|
Beckmann R, Jontofson R, Ketelsen UP, Kloke WD, Freund-Mölbert E. [Ultrastructural findings in experimental cortisone-induced myopathy and localized muscle damage following triamcinolone injection in a child]. MONATSSCHRIFT FUR KINDERHEILKUNDE 1970; 118:410-7. [PMID: 5523693] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
122
|
Lösel I, Schumacher G, Beckmann R, Schenck W. [Electrocardiographic findings in Friedreich's ataxia]. ARCHIV FUR KINDERHEILKUNDE 1970; 181:77-84. [PMID: 5517562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
|
123
|
Beckmann R, Teirich-Leube H. [Progressive muscular dystrophies and possibilities of their treatment]. THERAPIE DER GEGENWART 1970; 109:648 passim. [PMID: 5422181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
124
|
Karitzky D, Beckmann R, Rivat L. [A contribution to the immunology of the Louis-Bar syndrome: observations from one family]. MONATSSCHRIFT FUR KINDERHEILKUNDE 1970; 118:123-7. [PMID: 5000373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
125
|
Beckmann R, Teirich-Leube H. [Progressive muscular dystrophies and possibilities of their treatment. 1]. THERAPIE DER GEGENWART 1970; 109:485-6 passim. [PMID: 5424813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
126
|
Beckmann R, Manz F, Moser R. [Increased occurrence of "sporadic" spinal progressive muscular atrophy in infancy]. MONATSSCHRIFT FUR KINDERHEILKUNDE 1970; 118:41-4. [PMID: 5526771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
127
|
Beckmann R, Petith M. [Inosite: recent experimental and clinical findigs. Review of the literature and therapeutic experience]. DIE MEDIZINISCHE WELT 1970; 4:140-6. [PMID: 4910408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
128
|
|
129
|
Beckmann R, Brucker H, Krüger R, Reinwein H. [On the artificial feeding of infants during the 1st and 2d trimester. A clinical report]. DIE MEDIZINISCHE WELT 1969; 21:1221-5. [PMID: 5819838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
130
|
Beckmann R. [On the mechanism of action of biguanides in man]. ARZNEIMITTEL-FORSCHUNG 1969; 19:628-33. [PMID: 4891526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
131
|
Beckmann R. [Experience with and considerations on therapy of progressive muscular dystrophies]. HIPPOKRATES 1968; 39:876-88. [PMID: 5718770] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
132
|
Beckmann R, Bottermann P, Dieterle P. Zur renalen Ausscheidung von Buformin bei niereninsuffizienten Patienten. Eur J Clin Pharmacol 1968. [DOI: 10.1007/bf00418706] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
133
|
Beckmann R. [Current status of experience and concepts concerning the therapy of progressive muscular dystrophies]. MONATSSCHRIFT FUR KINDERHEILKUNDE 1968; 116:535-9. [PMID: 4889952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
134
|
|
135
|
|
136
|
Beckmann R. [Amino acid stained card findings in progressive muscular dystrophy (familial findings)]. MONATSSCHRIFT FUR KINDERHEILKUNDE 1967; 115:285-7. [PMID: 5592536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
137
|
Beckmann R, Ritter H. Aminoaciduria in progressive muscular dystrophy. A family study. GERMAN MEDICAL MONTHLY 1967; 12:76-80. [PMID: 6044995] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
138
|
Beckmann R, Ritter H. [Amino acid plotting charts in progressive muscular dystrophy. Family studies]. Dtsch Med Wochenschr 1966; 91:2231-5. [PMID: 5926730] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
139
|
|
140
|
Beckmann R. [On the behavior of benzilic acid-(N,N-dimethyl-2-hydroxymethylpiperidinium)estermethylsulfate in the organism]. ARZNEIMITTEL-FORSCHUNG 1966; 16:910-8. [PMID: 6014723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
141
|
Beckmann R. The mechanism of action of the biguanides. GERMAN MEDICAL MONTHLY 1966; 11:107-12. [PMID: 5326254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
142
|
Beckmann R. [On he concept of pseudomuscular dystrophic polymyositis]. ARCHIV FUR KLINISCHE UND EXPERIMENTELLE DERMATOLOGIE 1966; 227:309-17. [PMID: 5988397 DOI: 10.1007/bf00502846] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
143
|
Beckmann R, von Osten V. [Therapeutic possibilities in progressive muscular dystrophy]. Dtsch Med Wochenschr 1966; 91:108-16. [PMID: 5901816 DOI: 10.1055/s-0028-1110528] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
144
|
Beckmann R, Reinwein H. [Comparative chemical serological studies on clinically normal infants on different diets during early infancy]. DIE MEDIZINISCHE WELT 1966; 2:91-5. [PMID: 6006584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
145
|
Beckmann R. [Therapeutic possibilities in myopathies, specifically in progressive muscular dystrophy]. ARCHIV FUR KINDERHEILKUNDE 1965; 173:109-34. [PMID: 5329080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
146
|
|
147
|
Beckmann R, Hübner G. [On the pharmacokinetics of 1-butyl-biguanide hydrochloride and the prolonged-action form of this substance]. ARZNEIMITTEL-FORSCHUNG 1965; 15:765-70. [PMID: 5898679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
148
|
Beckmann R. �ber die Verteilung im Organismus und den biologischen Abbau von N-Phthalyl-glutamins�ure-imid-[14C] (Thalidomid-[14C]). Naunyn Schmiedebergs Arch Pharmacol 1962. [DOI: 10.1007/bf00260078] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
149
|
Osterloh G, Proske G, Beckmann R, Mückter H. Neuere Ergebnisse zur Chemie, Pharmakologie und Biochemie der Biguanide. Naunyn Schmiedebergs Arch Pharmacol 1961. [DOI: 10.1007/bf02433507] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|